PUBLISHER: AnalystView Market Insights | PRODUCT CODE: 1193435
PUBLISHER: AnalystView Market Insights | PRODUCT CODE: 1193435
Epigenetics-Based Instruments Market size was valued at USD 1,409.8 Million in 2022, expanding at a CAGR of 16.9% from 2023 to 2030.
Epigenetics-based instruments are any of the several medical tools and parts used to carry out activities and services based on epigenetics. These tools make up a sizable portion of the equipment required to carry out epigenetics-based research. Epigenetics is a branch of life science research that focuses on identifying and tracking gene-phenotype interactions.
One of the key drivers propelling the market for epigenetics-based instruments is the rise in cancer incidence around the world. The expansion of the market is accelerated by the government and public organizations that encourage funding and support for research and development, as well as product development activities related to the subject of epigenetics. The market is also influenced by the growing requirement to comprehend molecular-level epigenetic alterations, the creation of therapeutic solutions, and epigenetics research aimed at identifying treatment alternatives for diverse tumor kinds. Additionally, the market for epigenetics-based instruments is favorably impacted by population growth, changes in insurance coverage, the expansion of pharmaceutical and biotechnology firms, enhanced healthcare infrastructure, and the use of technology to reduce sequencing costs and time.
Further, the key businesses in the entire molecular diagnostics environment have benefited financially from the quick technology advancements and their concurrent acceptance by end customers. Both established, market-dominating enterprises and new, disruptive ones are playing a significant role in the rapid evolution of the diagnostics and biotech sectors toward the regularization of epigenetics in clinical settings. A rise in product introductions, knowledge of non-oncological diseases and epigenetics, and emphasis on the implementation of precision medicine strategies have also occurred in recent years. These initiatives are expected positively impact market growth over the forecast period.
The Global Epigenetics-Based Instruments Market is segmented on the basis of Technology, Application, End User, and Region.
The market is split into six categories based on Technology: DNA methylation, histone methylation, histone acetylation, large non-coding RNA, MicroRNA modification, and chromatin structures. The DNA methylation segment dominates the market. Growing demand for DNA methylation in DNA epigenetics is mainly contributing to segment growth.
The market is segmented into five categories based on application: oncology, non-oncology, development biology, drug discovery and others. The oncology segment dominates the market and is likely to maintain its dominance during the forecast period. This is partly due to a rise in the demand for therapy-based diagnostics for treating inflammatory diseases.
The market is segmented into three categories based on end user: academic research, pharma & biotech, and others. The clinical research segment dominates the market and is likely to maintain its dominance during the forecast period. This is partly due to an increase in the number of research project activities in Epigenetics-Based Instruments is boosting the segment growth.
The worldwide market for Epigenetics-Based Instruments is moderately fragmented in nature which comprised of large and small-sized market players with few large dominating the global market share. The companies in market emphasize on adopting aggressive strategies to reach out large consumer base. Some of the primary techniques used by corporations to strengthen their reach and expand their market share include new technology launches, partnerships, distribution network development, R&D spending, and mergers and acquisitions.
For instance, in January 2023, Amaryllis Nucleics, a startup based in the Bay Area U.S., was acquired by Active Motif Inc. The latter company anticipated to use this acquisition to develop novel synthesis chemistry.
Key features of the study:
This proposed research study on Epigenetics-Based Instruments market provides market size (US$ million), compound annual growth rate (CAGR %) and forecast estimation (2023-2030), considering 2022 as the base year
The research report elucidates potential growth opportunities across different segments/countries and explains attractive investment proposition matrix for Epigenetics-Based Instruments market
The overall report identifies new investment opportunities, challenges faced by established players, and growth factors to sustain in the Epigenetics-Based Instruments market
Impact of COVID-19 on Epigenetics-Based Instruments market size, forecast, CAGR, and market dynamics are discussed in detail under the research scope. Detailed insight on Epigenetics-Based Instruments market post-COVID will also be covered.
In order to give the users of this report a comprehensive view on the Epigenetics-Based Instruments market, we have also included competitive landscape and key innovator analysis for the Epigenetics-Based Instruments market.
The study encompasses a growth prospect mapping analysis, wherein all the industry segments are benchmarked based on their market size, growth rate and attractiveness.
The report offers detailed company profiling featuring major market participants which will help users to understand their financial information and strategic initiatives of players operating in the Epigenetics-Based Instruments market.
In addition, the report also unveil the important acquisitions & mergers, collaborations & joint ventures, new launch, research & development, regional expansion of major participants involved in the market on global as well as regional level.
The global Epigenetics-Based Instruments market report primarily caters to various stakeholders in this industry including suppliers, investors, new entrants, distributors, and financial analysts
SCOPE OF THE REPORT
The scope of this report covers the market by its major segments, which include as follows:
GLOBAL EPIGENETICS-BASED INSTRUMENTS MARKET KEY PLAYERS
Thermo Fisher Scientific Inc.
Pacific Biosciences of California Inc.
Active Motif Inc.
Bio-Rad Laboratories Inc.
New England Biolabs Inc.
F. Hoffmann-La Roche Ltd.
Active Motif, Inc.
GLOBAL EPIGENETICS-BASED INSTRUMENTS MARKET, BY TECHNOLOGY
Large non-coding RNA
GLOBAL EPIGENETICS-BASED INSTRUMENTS MARKET, BY APPLICATION
GLOBAL EPIGENETICS-BASED INSTRUMENTS MARKET, BY END USER
Pharma & biotech
GLOBAL EPIGENETICS-BASED INSTRUMENTS MARKET, BY REGION
Rest of Europe
Rest of APAC
Rest of LATAM
The Middle East and Africa
United Arab Emirates
Rest of MEA